IMO Health's recognition in the data analytics category highlights its ability to transform disorganized, incomplete clinical data into actionable insights. By standardizing data with 99% accuracy and ...
CAMBRIDGE, Mass.-- (BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced that it will be presenting data from preclinical studies of its Toll-like receptor (TLR) inhibitor, ...
Idera Pharmaceuticals, Inc. IDRA announced today the presentation of IMO-3100 mechanism of action data in a preclinical model of arthritis. In this study, the improvements in disease-related ...
CHICAGO, Dec. 10, 2024 /PRNewswire/ -- Intelligent Medical Objects, LLC (IMO Health) proudly received two 2024 Best in Business Awards in the categories of data analytics and healthcare IT. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results